Iwicki Mark T's Form 4 filing
KALA BIO, Inc. (KALA) · filed Jan 5, 2024
- Accession no.
- 0001415889-24-000769
- Filed
- Jan 5, 2024
- Trade date
- Jan 4, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $30.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Iwicki Mark TCIK 0001415537 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | Common Stock | AGrant or awardAcquired | +14,300 | $0.00 | $0 | 290,854 | Direct | |
| Jan 4, 2024 | Common Stock | SSaleDisposed | −4,539 | $6.73 | −$30,547.47 | 286,315 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | Common Stock | AGrant or awardAcquired | +64,500 | $0.00 | $0 | 64,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.